⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2008Thrombosis and Haemostasis

Thrombin and protease-activated receptors (PARs) in atherothrombosis

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

LMLluís MartorellConsejo Superior de Investigaciones Científicas CRCristina Rodrı́guezUniversity of Washington Medical Center MGMaurizio GentileHospital de Sant Pau

Discussion

Loading...

Member takes

Implication

May guide PAR-targeted antithrombotic development; leaves open clinical validation in randomized trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martorell et al. (2008) studied this question.

synapsesocial.com/papers/69d975e7a1d151c65f684309 https://doi.org/10.1160/th07-08-0481

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Protease-Activated Receptors in Cardiovascular Diseases2006 · 293 citations
2Protease-activated receptor 2: activation, signalling and function2003 · 125 citations
3Rho and Rac but not Cdc42 regulate endothelial cell permeability2001 · 467 citations
4Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors2003 · 157 citations
5Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/Phosphatase1999 · 31 citations